VIRX

Viracta Therapeutics, Inc. Common Stock
VIRX

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

VIRX was delisted on the 3rd of February, 2025.

Back to rankings

0 hedge funds and large institutions have $0 invested in Viracta Therapeutics, Inc. Common Stock in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less funds holding in top 10

Funds holding in top 10: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
–
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

1
-$2.19K
2
-$860
3
-$384
4
BBA
Baader Bank Aktiengesellschaft
Germany
-$283
Name Holding Trade Value Shares
Change 		Change in
Stake
XT
1
XTX Topco
Cayman Islands
–
UCFA
2
United Capital Financial Advisors
Texas
–
WA
3
WealthTrust Axiom
Pennsylvania
–
BBA
4
Baader Bank Aktiengesellschaft
Germany
–
RM
5
RP Management
New York
–